Info
Ownership

Karen A. Dawes - Insider Trading & Ownership

Location: 579 Bellevue Ave, Newport, RI
Summary: The estimated net worth of Karen A. Dawes is at least $12.8M dollars as of June 11, 2025. Karen A. Dawes is the Director of REPLIGEN CORP and owns shares of REPLIGEN CORP (RGEN) stock worth about $12.8M.
Signature: /s/ William Enright, Attorney-in-Fact
All Insider Reports: All Insider Reports

Ownership of Karen A. Dawes

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
RGEN	REPLIGEN CORP	Director	$12.8M			May 15, 2025
BRNS	Barinthus Biotherapeutics plc.	Director				Jun 10, 2025

Showing 1 to 2 of 2 entries

Insider Transactions Reported by Karen A. Dawes:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
BRNS	Barinthus Biotherapeutics plc.	Share Option (Right to Buy)	Award		$0	0.00	+20.2K	20.2K	6/10/2025	Direct
RGEN	Repligen Corp	Common Stock	Award	+1.07%	$0	0.00	+973	92.1K	5/15/2025	Direct
RGEN	Repligen Corp	Stock Option (Right to Buy)	Award		$0	0.00	+1.8K	1.8K	5/15/2025	Direct
RGEN	Repligen Corp	Common Stock	Options Exercise	+3.47%	$200K	67.71	+2.95K	88.2K	6/14/2024	Direct
RGEN	Repligen Corp	Stock Option (Right to Buy)	Options Exercise		$0	0.00^*	+2.95K	0	6/14/2024	Direct
RGEN	Repligen Corp	Common Stock	Award	+0.92%	$0	0.00	+803	88.2K	5/16/2024	Direct
RGEN	Repligen Corp	Stock Option (Right to Buy)	Award		$0	0.00	+1.58K	1.58K	5/16/2024	Direct
BRNS	Barinthus Biotherapeutics plc.	Share Option (Right to Buy)	Award		$0	0.00	+19.5K	19.5K	5/10/2024	Direct
RGEN	Repligen Corp	Common Stock	Sale	-1.13%	-$193K	193.35	-1K	87.4K	2/27/2024	Direct
RGEN	Repligen Corp	Common Stock	Options Exercise	+5.52%	$195K	42.07	+4.63K	88.4K	2/27/2024	Direct
RGEN	Repligen Corp	Stock Option (Right to Buy)	Options Exercise		$0	0.00^*	+4.63K	0	2/27/2024	Direct
RGEN	Repligen Corp	Common Stock	Options Exercise	+9.58%	$134K	18.12	+7.39K	84.6K	8/29/2023	Direct
RGEN	Repligen Corp	Common Stock	Sale	-1%	-$146K	171.38	-850	83.7K	8/29/2023	Direct
RGEN	Repligen Corp	Stock Option (Right to Buy)	Options Exercise		$0	0.00^*	+7.39K	0	8/29/2023	Direct
RGEN	Repligen Corp	Common Stock	Award	+1.04%	$0	0.00	+798	77.2K	5/18/2023	Direct
RGEN	Repligen Corp	Stock Option (Right to Buy)	Award		$0	0.00	+1.73K	1.73K	5/18/2023	Direct
VACC	Vaccitech plc	Share Option (Right to Buy)	Award		$0	0.00	+19.2K	19.2K	5/11/2023	Direct
RGEN	Repligen Corp	Common Stock	Sale	-1%	-$176K	227.17	-775	76.4K	9/9/2022	Direct
VACC	Vaccitech plc	Share Option (Right to Buy)	Award		$0	0.00	+18.6K	18.6K	6/15/2022	Direct
RGEN	Repligen Corp	Common Stock	Award	+0.84%	$0	0.00	+644	77.2K	5/26/2022	Direct
RGEN	Repligen Corp	Stock Option (Right to Buy)	Award		$0	0.00	+1.57K	1.57K	5/26/2022	Direct
RGEN	Repligen Corp	Common Stock	Sale	-16.1%	-$2.21M	150.51	-14.7K	76.5K	5/25/2022	Direct
RGEN	Repligen Corp	Common Stock	Sale	-4.98%	-$1.26M	263.93	-4.78K	91.2K	11/10/2021	Direct
RGEN	Repligen Corp	Common Stock	Options Exercise	-4.74%	-$125K	26.12	-4.78K	96K	11/10/2021	Direct
RGEN	Repligen Corp	Stock Option (Right to Buy)	Options Exercise		$0	0.00^*	+4.78K	0	11/10/2021	Direct
RGEN	Repligen Corp	Common Stock	Sale	-2.56%	-$729K	303.94	-2.4K	91.2K	11/2/2021	Direct
RGEN	Repligen Corp	Common Stock	Sale	-0.29%	-$80.6K	294.26	-274	93.6K	9/14/2021	Direct
RGEN	Repligen Corp	Common Stock	Sale	-3.55%	-$982K	283.91	-3.46K	93.9K	9/1/2021	Direct
RGEN	Repligen Corp	Common Stock	Options Exercise	-3.43%	-$134K	38.76	-3.46K	97.4K	9/1/2021	Direct
RGEN	Repligen Corp	Stock Option (Right to Buy)	Options Exercise		$0	0.00^*	+3.46K	0	9/1/2021	Direct
RGEN	Repligen Corp	Common Stock	Sale	-1.47%	-$363K	259.03	-1.4K	94K	8/18/2021	Direct
RGEN	Repligen Corp	Common Stock	Sale	+0.04%	$10.5K	262.31	+40	93.9K	8/18/2021	Direct
RGEN	Repligen Corp	Common Stock	Sale	-15.5%	-$4.44M	253.77	-17.5K	95.4K	8/17/2021	Direct
RGEN	Repligen Corp	Common Stock	Sale	-3.9%	-$927K	202.09	-4.59K	113K	7/20/2021	Direct
RGEN	Repligen Corp	Common Stock	Sale	-1.28%	-$307K	202.23	-1.52K	117K	7/13/2021	Direct
RGEN	Repligen Corp	Common Stock	Options Exercise	+2.52%	$121K	41.19	+2.93K	119K	7/13/2021	Direct
RGEN	Repligen Corp	Stock Option (Right to Buy)	Options Exercise		$0	0.00^*	+2.93K	0	7/13/2021	Direct
RGEN	Repligen Corp	Common Stock	Award	+0.52%	$0	0.00	+604	116K	5/13/2021	Direct
RGEN	Repligen Corp	Stock Option (Right to Buy)	Award		$0	0.00	+1.52K	1.52K	5/13/2021	Direct
RGEN	Repligen Corp	Common Stock	Sale	-0.25%	-$50.4K	176.85	-285	115K	5/11/2021	Direct
RGEN	Repligen Corp	Common Stock	Options Exercise	+14.9%	$48.3K	3.22	+15K	116K	5/11/2021	Direct
RGEN	Repligen Corp	Stock Option (Right to Buy)	Options Exercise	-100%	$0	0.00^*	-15K	0	5/11/2021	Direct

Previous1Next

Showing 1 to 42 of 42 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.